Artificial intelligence for clinical oncology
- PMID: 33930310
- PMCID: PMC8282694
- DOI: 10.1016/j.ccell.2021.04.002
Artificial intelligence for clinical oncology
Abstract
Clinical oncology is experiencing rapid growth in data that are collected to enhance cancer care. With recent advances in the field of artificial intelligence (AI), there is now a computational basis to integrate and synthesize this growing body of multi-dimensional data, deduce patterns, and predict outcomes to improve shared patient and clinician decision making. While there is high potential, significant challenges remain. In this perspective, we propose a pathway of clinical cancer care touchpoints for narrow-task AI applications and review a selection of applications. We describe the challenges faced in the clinical translation of AI and propose solutions. We also suggest paths forward in weaving AI into individualized patient care, with an emphasis on clinical validity, utility, and usability. By illuminating these issues in the context of current AI applications for clinical oncology, we hope to help advance meaningful investigations that will ultimately translate to real-world clinical use.
Keywords: artificial intelligence; care pathway; clinical oncology; clinical translation; precision medicine.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declarations of interests H.J.W.L.A. is a shareholder of and receives consulting fees from Onc.Ai and BMS, outside submitted work. A.H. is a shareholder of and receives consulting fees from Altis Labs, outside submitted work.
Figures



Similar articles
-
Molecular-based precision oncology clinical decision making augmented by artificial intelligence.Emerg Top Life Sci. 2021 Dec 21;5(6):757-764. doi: 10.1042/ETLS20210220. Emerg Top Life Sci. 2021. PMID: 34874054 Free PMC article. Review.
-
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology.Cancer Med. 2024 Jun;13(12):e7398. doi: 10.1002/cam4.7398. Cancer Med. 2024. PMID: 38923826 Free PMC article. Review.
-
Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.Oncologist. 2019 Jun;24(6):772-782. doi: 10.1634/theoncologist.2018-0257. Epub 2018 Nov 16. Oncologist. 2019. PMID: 30446581 Free PMC article.
-
Integrating Artificial Intelligence-Driven Wearable Technology in Oncology Decision-Making: A Narrative Review.Oncology. 2025;103(1):69-82. doi: 10.1159/000540494. Epub 2024 Jul 25. Oncology. 2025. PMID: 39072365 Free PMC article. Review.
-
Artificial intelligence-assisted selection and efficacy prediction of antineoplastic strategies for precision cancer therapy.Semin Cancer Biol. 2023 May;90:57-72. doi: 10.1016/j.semcancer.2023.02.005. Epub 2023 Feb 14. Semin Cancer Biol. 2023. PMID: 36796530 Review.
Cited by
-
Introduction to the Special Issue on "Role of Novel Imaging Technique in Brain Tumors".Cancers (Basel). 2024 Jan 30;16(3):575. doi: 10.3390/cancers16030575. Cancers (Basel). 2024. PMID: 38339326 Free PMC article.
-
Development and Validation of a Machine Learning Algorithm Predicting Emergency Department Use and Unplanned Hospitalization in Patients With Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg. 2022 Aug 1;148(8):764-772. doi: 10.1001/jamaoto.2022.1629. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35771564 Free PMC article.
-
Role of artificial intelligence in digital pathology for gynecological cancers.Comput Struct Biotechnol J. 2024 Mar 11;24:205-212. doi: 10.1016/j.csbj.2024.03.007. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 38510535 Free PMC article. Review.
-
Optimizing the Clinical Direction of Artificial Intelligence With Health Policy: A Narrative Review of the Literature.Cureus. 2024 Apr 16;16(4):e58400. doi: 10.7759/cureus.58400. eCollection 2024 Apr. Cureus. 2024. PMID: 38756258 Free PMC article. Review.
-
Unraveling the Mysteries of Alzheimer's Disease Using Artificial Intelligence.Rev Recent Clin Trials. 2025;20(2):124-141. doi: 10.2174/0115748871330861241030143321. Rev Recent Clin Trials. 2025. PMID: 39563218 Review.
References
-
- Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, and Winchester DP (2017). The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin 67, 93–99. - PubMed
-
- Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L, Tse D, Etemadi M, Ye W, Corrado G, et al. (2019). End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat. Med 25, 954–961. - PubMed
-
- Bari A, Marcheselli L, Sacchi S, Marcheselli R, Pozzi S, Ferri P, Balleari E, Musto P, Neri S, Aloe Spiriti MA, et al. (2010). Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann. Oncol 21, 1486–1491. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical